Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
RELATED APPLICATIONS
This application is a divisional of U.S. patent application Ser. No. 10/325,457,filed on Dec. 19, 2002 (U.S. Pat. No. 6,949,342), which claims the benefit of U.S. Provisional Application No. 60/343,448, filed Dec. 21, 2001. The entire teachings of the above application are incorporated herein by reference.
